secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cadrenal Therapeutics, Inc. (CVKD)
CIK:        0001937993
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001213900-24-021512
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cadrenal Therapeutics enters ATM agreement with H.C. Wainwright for up to $5.14M in common stock
--------------------------------------------------------------------------------

- Entered ATM agreement with H.C. Wainwright to sell up to $5,143,730 of common stock from time to time.
- Sales agent compensation is 3.0% of gross proceeds; no minimum sale obligation.
- Offering subject to effectiveness of Form S-3 registration statement filed March 11, 2024.
- Company can terminate agreement at any time; Wainwright can terminate on material adverse change.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024021512/0001213900-24-021512-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1937993/000121390024021512/ea0201524-8k_cadrenal.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-021512

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer